Atlas Trials

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Clinical trial NCT03234335 · COMPLETED

Trial details

NCT number
NCT03234335
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple MyelomaRenal Failure
Start date
2018-04-10
Primary completion
2020-09-29
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.